Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roka Bioscience Inc (ROKA)

Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Roka Bioscience, Inc. is a molecular diagnostics company. It is focused on developing and commercializing advanced testing solutions for the food safety testing market. Roka provides Atlas instrument, a fully automated molecular diagnostic testing instrument to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The company also offers atlas detection assays that include tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin-producing E. coli, and Listeria monocytogenes, as well as related consumable supplies. Roka Bioscience, Inc. is headquartered in Warren, New Jersey.

Fiscal Year End Date: 12/31

(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Sales 7,240 5,990 5,060 2,180 100
Sales Growth +20.87% +18.38% +132.11% +2,079.98% unch
Net Income -30,790 -36,600 -32,230 -29,570 -23,240
Net Income Growth +15.87% -13.56% -9.00% -27.24% unch
(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Total Assets 61,840 74,600 103,830 59,110 0
Total Assets Growth -17.10% -28.15% +75.66% unch unch
Total Liabilities 24,950 29,690 24,750 12,660 0
Total Liabilities Growth -15.97% +19.96% +95.50% unch unch
(Values in U.S. Thousands) Dec, 2016 Dec, 2015 Dec, 2014 Dec, 2013 Dec, 2012
Operating Cash Flow -22,800 -23,750 -23,520 -27,450 -27,770
Operating Cash Flow Growth +4.00% -0.98% +14.32% +1.15% unch
Net Cash Flow 5,390 -4,060 -25,230 15,410 -13,690
Change in Net Cash Flow +232.76% +83.91% -263.72% +212.56% unch
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar